Cosette Pharmaceuticals - M&A Summary and Business Overview

Life ScienceCompany

Cosette Pharmaceuticals M&A Summary

Cosette Pharmaceuticals has acquired 3 companies, including 3 in the last 5 years.

Cosette Pharmaceuticals’ largest acquisition to date was in 2025, when it acquired Mayne Pharma Group for $430M. Cosette Pharmaceuticals has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (100%).

Cosette Pharmaceuticals Business Overview

Where is Cosette Pharmaceuticals headquartered?

Cosette Pharmaceuticals is headquartered in Bridgewater, New Jersey.

What sector is Cosette Pharmaceuticals in?

Cosette Pharmaceuticals is a life science company.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 2
  • M&A Advisors 6

Cosette Pharmaceuticals

Cosette Pharmaceuticals, Inc.

200 Crossing Boulevard, 4th Floor,
Bridgewater, New Jersey 08807
United States,
(800) 922-1038
www.cosettepharma.com

Cosette Pharmaceuticals is a US-based, fully integrated pharmaceutical company with capabilities in product development, manufacturing, and commercial operations. The current products focus on complex dosage forms including topical creams, ointments, oral liquids/solutions, suppositories, and injectables. Cosette Pharmaceuticals is based in Bridgewater, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.6/yr) # - - 1 1 - 1 3
vol $171M $430M $601M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Mayne Pharma Group Ltd. 2025-02-20 430M USD Add-on Acquisition
Salisbury South, Australia · www.maynepharma.com
Vyleesi 2023-12-20 171M USD Divestiture
, United States · www.vyleesi.com
Daiichi Sankyo - Eight Branded Products 2022-01-18 - Divestiture
Tokyo, Japan
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 601M (100%) - -
Total 3 $601M - -

By Geo

State/Country Buy Value Sell Value
Australia 1 430M - -
Japan 1 - - -
United States 1 171M - -
Domestic 1 (33%) 171M (28%) - -
Cross-border 2 (67%) 430M (72%) - -
Total 3 $601M - -

Top M&A Advisors

Financial Deals
UBS Investment Bank
1
BofA Securities
1
Santander Corporate & Investment Banking
1
Legal Deals
Ropes & Gray
1
Morgan Lewis
1
Corrs Chambers Westgarth
1

Deal Values

buy # Total
$100M to $1B 2 $601M
TOTAL $601M
Largest Mayne Pharma Group Ltd.
$430M (2025-02-20)

M&A Connections

Deals
Acquired from
Strategic(s)
67%
2 (67%)

 Subscribe to unlock this and 211,744
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 205K M&A Transactions
  • 207K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.